This analysis evaluates the distributional impact of Empower Health intervention compared to usual care across wealth quintiles, regions, and sex in Kenya. The analysis includes: Health benefits: DALYs averted (disability-adjusted life years) - discounted at 3% Life years gained: Years of life saved (mortality benefit only) - NOT discounted (undiscounted) Cost burden: Incremental costs by equity stratifiers - discounted at 3% Concentration curves for health benefits, life years, and costs Cost-effectiveness ICERs by equity metric Kenya GDP per capita = $2,200 (WTP threshold) Important Note on Concentration Curve Interpretation: Curve below diagonal = Positive C-index (+) For Health Benefits/Life Years: PRO-RICH (richer gain more benefit) - INEQUITABLE For Costs: PROGRESSIVE (richer pay more) - EQUITABLE Curve above diagonal = Negative C-index (-) For Health Benefits/Life Years: PRO-POOR (poorer gain more benefit) - EQUITABLE For Costs: REGRESSIVE (poorer pay more) - INEQUITABLE

Covid system

Predict Autism Spectrum Disorder (ASD) - Data Analysis II

Chi-square goodness-of-fit tests applied to molecular marker data from mouse (backcross, 1:1 ratio) and maize (F2, 1:2:1 ratio) populations, with Bonferroni correction for multiple testing. Completed as part of FIT 678 — Genetic Data Analysis for Plant Breeding, Federal University of Viçosa, Brazil.